A targeted treatment for selected skin, lung, thyroid, brain, and other cancers.
Profile scope: Dabrafenib. Confirm the exact product and route; formulations and combination products are not interchangeable.
Possible side effects
Tiredness, digestive upset, body discomfort, or changes in skin may occur.
Serious risks and warning signs
Fever, dehydration, severe skin reactions, unusual bleeding, eye symptoms, or heart-related symptoms need prompt oncology advice. New skin cancers and other cancers can occur; changing moles or nonhealing lesions need review.
A question for your healthcare team
Which fever and skin changes require an immediate call, and how often should my eyes and skin be checked?
What to do with this information
Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.
Sources
Sources checked November 19, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.